Proteome Sciences plc

Direct answer

Proteome Sciences plc is publicly traded on LSE under the ticker PRM.L.

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other...

Can you invest in Proteome Sciences plc?

Yes. Proteome Sciences plc is publicly traded on LSE under the ticker PRM.L.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Proteome Sciences plc

Detailed equity research is provided by MarketSnap.